This important issue of Medical Clinics provides essential updates in heart failure. The following topics are covered: epidemiology, pathophysiology, and general approach for heart failure; symptoms, signs, diagnostic studies, and prognostic significance of systolic versus diastolic heart failure; the appropriate use of biomarkers; oral versus intravenous diuretic therapy; guideline-based therapy including RAAS blockade, beta-blockade, and aldosterone antagonist, appropriate use of AICD and biventricular pacing; role of ventricular assist device; pathophysiological consideration and management approaches in acute decompensated heart failure; pathophysiology and current approaches to cardiorenal syndrome; heart failure with other comorbidities including diabetes, obesity, anemia, and cancer; heart failure and atrial fibrillation; and the role of disease management strategies in heart failure.
1. Cover image - p. 1 2. Title page - p. 2 3. Table of Contents - p. 3 4. Forthcoming Issues - p. 4 5. CME Accreditation Page and Author Disclosure - p. 5 6. Contributors - p. 6 7. Heart Failure: A Common and Complex Clinical Syndrome - p. 7 8. The Epidemiology and Pathophysiology of Heart Failure - p. 8 9. Pathophysiology of Systolic and Diastolic Heart Failure - p. 15 10. The Appropriate Use of Biomarkers in Heart Failure - p. 20 11. Evidence-Based Therapy for Heart Failure - p. 28 12. Diuretics in Heart Failure - p. 36 13. Inotropic Therapy - p. 41 14. Renal Dysfunction in Heart Failure - p. 48 15. Management of Comorbid Conditions in Heart Failure - p. 59 16. Atrial Fibrillation in Heart Failure - p. 66 17. Breast Cancer Therapies and Cardiomyopathy - p. 74 18. Index - p. 84
This important issue of Medical Clinics provides essential updates in heart failure. The following topics are covered: epidemiology, pathophysiology, and general approach for heart failure; symptoms, signs, diagnostic studies, and prognostic significance of systolic versus diastolic heart failure; the appropriate use of biomarkers; oral versus intravenous diuretic therapy; guideline-based therapy including RAAS blockade, beta-blockade, and aldosterone antagonist, appropriate use of AICD and biventricular pacing; role of ventricular assist device; pathophysiological consideration and management approaches in acute decompensated heart failure; pathophysiology and current approaches to cardiorenal syndrome; heart failure with other comorbidities including diabetes, obesity, anemia, and cancer; heart failure and atrial fibrillation; and the role of disease management strategies in heart failure.
1. Cover image - p. 1 2. Title page - p. 2 3. Table of Contents - p. 3 4. Forthcoming Issues - p. 4 5. CME Accreditation Page and Author Disclosure - p. 5 6. Contributors - p. 6 7. Heart Failure: A Common and Complex Clinical Syndrome - p. 7 8. The Epidemiology and Pathophysiology of Heart Failure - p. 8 9. Pathophysiology of Systolic and Diastolic Heart Failure - p. 15 10. The Appropriate Use of Biomarkers in Heart Failure - p. 20 11. Evidence-Based Therapy for Heart Failure - p. 28 12. Diuretics in Heart Failure - p. 36 13. Inotropic Therapy - p. 41 14. Renal Dysfunction in Heart Failure - p. 48 15. Management of Comorbid Conditions in Heart Failure - p. 59 16. Atrial Fibrillation in Heart Failure - p. 66 17. Breast Cancer Therapies and Cardiomyopathy - p. 74 18. Index - p. 84
